Register for our free email digests:
Endo Pharmaceuticals Inc.
Division of Endo International PLC
www.endo.com/endopharma/home
Latest From Endo Pharmaceuticals Inc.
Sesen’s Phase III Bladder Cancer Results Spark Mixed Reactions
The updated data are in line with prior interim readouts but nonetheless triggered strong reactions. One analyst slashed their peak sales forecast for Vicinium, while another talked up the likelihood of rapid commercial adoption of the fusion protein-drug conjugate.
Teva Strikes Two Settlements Over ‘Pay-For-Delay’ Agreements
A California Court has secured four major settlements worth $70m with pharmaceutical companies over allegations of entering into collusive pay-for-delay agreements, including two with Teva.
FDA’s Gottlieb Says His Departure Won’t Stop Forward Progress On Key Initiatives
Outgoing commissioner say he has 'extreme confidence' in soon-to-be-acting Commissioner Ned Sharpless and other agency leaders, and expects initiatives advanced during his tenure will be ‘encapsulated and enshrined in regulation and policy’ because they are built on a solid administrative record.
Surprise Approval For Clarus' Oral Testosterone Includes Black Box, No REMS
Company Information
- Industry
-
Pharmaceuticals
- Specialty Pharmaceuticals
- Therapeutic Areas
- Cancer
- Gynecological, Urological
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Endo International PLC
- Senior Management
- Contact Info
-
Endo Pharmaceuticals Inc.
Phone: (484) 216-0000
1400 Atwater Dr.
Malvern, PA 19355
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice